All In Biotech

Free tool

FAERS Monitor: Narcan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208411 or its brand name (Narcan, Naloxone Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

4,866

Serious

3,463

71% of reports

Hospitalization

1,880

Death reported

743

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea389
  • fatigue365
  • pain347
  • death301
  • vomiting291
  • diarrhoea272
  • dyspnoea248
  • off label use245
  • toxicity to various agents230
  • drug ineffective223
  • headache219
  • overdose213
  • fall206
  • pneumonia183
  • anxiety171

Reports by year received

View as table
YearReports
200410
200512
20069
200718
200833
200924
201037
201139
201237
201321
201443
201555
2016186
2017110
2018245
2019330
2020644
2021508
2022477
2023521
2024538
2025608
2026361

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,293 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
toxicity to various agentsSignal2305.95.2938
overdoseSignal2134.33.7535
fallSignal2062.72.3218
vomitingSignal2912.72.4311
anxietySignal1712.62.2169
pneumoniaSignal1832.42.1157
painSignal3472.42.2303
nauseaSignal3892.11.9239
fatigueSignal3652.01.8196
dyspnoea2481.91.7107
diarrhoea2721.81.6103
death3011.51.454
headache2191.51.338
off label use2451.21.19
drug ineffective2230.70.623

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.